Product Development Stories
Will Vista Gold (USA Stocks:VGZ) turn things around in April?
a day ago at Macroaxis By Rifka Kats |
Approximately 27.0% of Vista Gold's outstanding shares are held by institutional investors. Insider ownership in Vista Gold pertains to the equity held by the company's officers, directors, leadership team relatives, or anyone with access to non-public information. For our latest analysis of Vista, including current ownership details, refer to our ownership diagnostics.
Main Points
Despite a loss in net income from continuing operations of 6.4M and a negative return on assets of 0.42, Vista Gold (VGZ) presents a potential investment opportunity due to its positive accumulation distribution of 0.11 and a recent price change increase of 0.05. With a book value of 0.041 and an open price of 0.48, the gold industry player is poised for a bullish turnaround in April, backed by its daily balance of power at 0.8333, indicating strong buying pressure. Continue Reading...- VGZ Vista Gold
- VGZ 0.52 -0.01
- Low 0.51
- High 0.54
- Volume 178.3 K
- Alpha 0.46
- Beta -0.73
- Return On Equity -0.88
- Return On Asset -0.42
- Current Valuation 58.33 M
- Shares Outstanding 121.53 M
- Shares Owned By Insiders 3.79 %
- Shares Owned By Institutions 27.40 %
- Number Of Shares Shorted 207.16 K
- Price To Earning 183.43 X
- Price To Book 13.01 X
- EBITDA 139 M
- Net Income (6.58 B)
- Cash And Equivalents 8.11 M
- Cash Per Share 0.08 X
- Debt To Equity 0 %
- Current Ratio 10.97 X
- Book Value Per Share 0.04 X
- Cash Flow From Operations (5.86 B)
- Short Ratio 0.88 X
- Earnings Per Share (0.05) X
- Target Price 2.5
- Number Of Employees 12
- Beta 1.59
- Market Capitalization 64.4 M
- Total Asset 8.93 B
- Retained Earnings (471.4 B)
- Working Capital 7.71 M
- Current Asset 15.2 M
- Current Liabilities 803 K
- Z Score -73.82
- Net Asset 8.93 B
- Accumulation Distribution 9907.39
- Daily Balance Of Power (0.33)
- Rate Of Daily Change 0.98
- Day Median Price 0.53
- Day Typical Price 0.52
- Price Action Indicator (0.01)
- Period Momentum Indicator (0.01)
Macroaxis uses a strict editorial review process to publish stories and blog posts. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
The article provides an in-depth look at Fixed Assets Management Systems, tools designed to automate and streamline the management of an organization's fixed assets. These systems centralize data such as acquisition details, depreciation schedules, and maintenance records, offering benefits like enhanced efficiency, improved accuracy, cost control, and regulatory compliance.
a day ago at Macroaxis By Aina Ster |
Every cloud has a silver lining, and in the realm of the US stock market, UiPath Inc. (NYSE: PATH) might just be that glimmer of hope. This technology company, specializing in software and services, has been making waves in the software-infrastructure industry. Despite reporting a loss of $328.4M applicable to common shares and an EBITDA of $191.8M, the company's valuation market value stands at a robust $24.64B.
few days ago at Macroaxis By Vlad Skutelnik |
Archer Daniels Midland (ADM), a leading player in the Consumer Defensive sector, specifically in the Farm Products industry, has been a topic of interest for many investors. With an enterprise value of $37.2B and a market capitalization of $29.2B, this NYSE-listed company has shown a robust operating margin of 4.61%. Despite a quarterly revenue growth decline of 12%, the company managed to post a net income from continuing operations of $4.4B.
few days ago at Macroaxis By Rifka Kats |
Landstar System has an average rating of 'Hold' from 14 analysts. Macroaxis provides trading recommendations for Landstar System to complement and cross-verify the current analyst consensus on Landstar System. Our advice engine assesses the company's growth potential exclusively from the perspective of an investor's current risk tolerance and investment horizon.
Key Takeaways
Landstar System (LSTR) is a compelling investment opportunity in the industrials sector, specifically within the integrated freight and logistics industry.over a month ago at Macroaxis By Gabriel Shpitalnik |
US Bancorp, a prominent player in the Banks - Regional industry, has shown a potential downside with a maximum drawdown of 12.5% and a daily balance of power at -0.94. This suggests a possible performance dip in February. The company's open price stands at $42.15, while the day's typical price is slightly lower at $41.37, indicating a potential for loss.
over two months ago at Macroaxis By Aina Ster |
United Community Banks (NASDAQ: UCBI), a key player in the domestic regional banking industry, is currently under scrutiny as potential indicators point towards a possible downtrend in February. With a market capitalization of $3.4 billion and a workforce of 3.2K full-time employees, the bank has been a steady performer with a return on assets of 1.01% and an operating margin of 37.6%. However, the current quarter's EPS estimate stands at $0.45, a figure that may not meet the expectations of some investors.
over two months ago at Macroaxis By Vlad Skutelnik |
Cal-Maine Foods, a leading player in the Packaged Foods & Meats sector, has seen a slight dip of 1.24% in its stock price, presenting a potential buying opportunity for investors. The company has a robust operating income of 967.7M, indicating strong financial health. Despite a quarterly earnings growth reported as a loss of 0.99, the company's PEG ratio of 0.75 suggests that the stock may be undervalued, providing room for potential upside of 3.97.
Main Takeaways
The company, Cal Maine Foods, reported last year's revenue of $3.15 billion.over two months ago at Macroaxis By Raphi Shpitalnik |
Freeline Therapeutics Holdings Plc is currently overvalued at $5.58 per share, given its modest future projections. On a performance scale of 0 to 100, Freeline Therapeutics scores a 9. The company has a Beta (market volatility) of -0.4497, suggesting potential diversification benefits within a portfolio.
over two months ago at Macroaxis By Rifka Kats |
Redhill Biopharma (RDHL), a player in the Drug Manufacturers - Specialty & Generic industry, has been making strides in its product pipeline, despite a challenging financial performance with an operating margin of -2.45 and a diluted EPS of -8.0. However, the company's enterprise value revenue ratio of 0.64 and book value of 1.09 suggest underlying value. The firm's significant investment in R&D, reflected in its $71.7M loss before tax, could potentially lead to breakthroughs and a turnaround in its financial performance.
Important Highlights
Redhill Biopharma is currently undervalued, trading at $11.05 per share, with modest growth projections on the horizon.over two months ago at Macroaxis By Gabriel Shpitalnik |